killexams.com CDCA-ADEX real questions with PDF Questions

Our own CDCA-ADEX test prep Exam dumps provides all of a person that you ought to have the qualification exam. Our own Medical CDCA-ADEX Exam will provide you test queries with valid solutions that are specific copies of the actual Dental Hygiene exam. High quality and ready with regard to the CDCA-ADEX Exam. All of us at killexams.com 100% guarantee in order to empower you in order to definitely pass your own CDCA-ADEX test with higher scores.

Exam Code: CDCA-ADEX Practice test 2022 by Killexams.com team
Dental Hygiene
Medical Hygiene availability
Killexams : Medical Hygiene availability - BingNews https://killexams.com/pass4sure/exam-detail/CDCA-ADEX Search results Killexams : Medical Hygiene availability - BingNews https://killexams.com/pass4sure/exam-detail/CDCA-ADEX https://killexams.com/exam_list/Medical Killexams : Medical & Hygiene PP Non Woven Fabric Market Report, In-Depth Market Analysis and FORECAST 2022 To 2028 of market insights.

The MarketWatch News Department was not involved in the creation of this content.

Nov 04, 2022 (Reportmines via Comtex) -- Pre and Post Covid is covered and Report Customization is available.

The "Medical & Hygiene PP Non Woven Fabric market" value is projected to grow during 2022 - 2028. This market research report on Medical & Hygiene PP Non Woven Fabric market provides a holistic analysis of the market size and market trends and this entire report is of 190 pages. The report contains information about the key players in the Medical & Hygiene PP Non Woven Fabric market Cardinal Health,Berry Plastics,3M,Molnlycke Health Care,Halyard Health,Hartmann,Ahlstrom,Domtar Corporation,Medtronic,B. Braun,Intco Medical,Hogy Medical,Advanced Fabrics (SAAF),Ansell Healthcare,Medline Industries.

The global Medical & Hygiene PP Non Woven Fabric market size is projected to reach multi million by 2028, in comparision to 2021, at unexpected CAGR during 2022-2028 (Ask for trial Report).

The report offers detailed coverage of Medical & Hygiene PP Non Woven Fabric market growth drivers, price trends, demand, and market challenges. The global Medical & Hygiene PP Non Woven Fabric Market is categorized by type, region, and Application. This includes Market type - Drylaid,Airlaid,Wetlaid,Spunlaid and Market application - Level 1 Surgical Gowns,Level 2 Surgical Gowns,Level 3 Surgical Gowns,Level 4 Surgical Gowns,Surgical Mask, Geographical segmentation - North America: United States, Canada, Europe: GermanyFrance, U.K., Italy, Russia,Asia-Pacific: China, Japan, South, India, Australia, China, Indonesia, Thailand, Malaysia, Latin America:Mexico, Brazil, Argentina, Colombia, Middle East & Africa:Turkey, Saudi, Arabia, UAE, Korea helps Medical & Hygiene PP Non Woven Fabric market focus their marketing efforts specifically on their defined area of interest, therefore avoiding inefficient spending.

Get trial PDF of Medical & Hygiene PP Non Woven Fabric Market Report https://www.predictivemarketresearch.com/enquiry/request-sample/1023973

Medical & Hygiene PP Non Woven Fabric Market Players

The top competitors in the market, as highlighted in the report, are:

  • Cardinal Health
  • Berry Plastics
  • 3M
  • Molnlycke Health Care
  • Halyard Health
  • Hartmann
  • Ahlstrom
  • Domtar Corporation
  • Medtronic
  • B. Braun
  • Intco Medical
  • Hogy Medical
  • Advanced Fabrics (SAAF)
  • Ansell Healthcare
  • Medline Industries

Market Segmentation

The worldwide Medical & Hygiene PP Non Woven Fabric Market is categorized into Component, Deployment, Application, and Region.

In terms of Components, the Medical & Hygiene PP Non Woven Fabric Market is segmented into:

  • Cardinal Health
  • Berry Plastics
  • 3M
  • Molnlycke Health Care
  • Halyard Health
  • Hartmann
  • Ahlstrom
  • Domtar Corporation
  • Medtronic
  • B. Braun
  • Intco Medical
  • Hogy Medical
  • Advanced Fabrics (SAAF)
  • Ansell Healthcare
  • Medline Industries

The Medical & Hygiene PP Non Woven Fabric Market Analysis by types is segmented into:

  • Drylaid
  • Airlaid
  • Wetlaid
  • Spunlaid

The Medical & Hygiene PP Non Woven Fabric Market Industry Research by Application is segmented into:

  • Level 1 Surgical Gowns
  • Level 2 Surgical Gowns
  • Level 3 Surgical Gowns
  • Level 4 Surgical Gowns
  • Surgical Mask

In terms of Region, the Medical & Hygiene PP Non Woven Fabric Market Players available by Region are:

  • North America:
  • Europe:
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific:
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • China Taiwan
    • Indonesia
    • Thailand
    • Malaysia
  • Latin America:
    • Mexico
    • Brazil
    • Argentina Korea
    • Colombia
  • Middle East & Africa:
    • Turkey
    • Saudi
    • Arabia
    • UAE
    • Korea

Inquire Your Questions If Any Before Purchasing This Report https://www.predictivemarketresearch.com/enquiry/pre-order-enquiry/1023973

Key Benefits for Industry Participants & Stakeholders

  • The Medical & Hygiene PP Non Woven Fabric Market Research allows investors to understand the industry's market size and dynamics and the growth contributors of the Medical & Hygiene PP Non Woven Fabric.
  • This Medical & Hygiene PP Non Woven Fabric Market Research Report provides a comprehensive analysis of the growing popularity of theMedical & Hygiene PP Non Woven Fabric and how this growth can be leveraged by the stakeholders.
  • The competitor analysis framework will work well for entrepreneurs, business owners, startup founders, product managers, and marketers and the top competitors include Cardinal Health,Berry Plastics,3M,Molnlycke Health Care,Halyard Health,Hartmann,Ahlstrom,Domtar Corporation,Medtronic,B. Braun,Intco Medical,Hogy Medical,Advanced Fabrics (SAAF),Ansell Healthcare,Medline Industries.

Kindly Use this TOC

  • Report Overview
  • Global Growth Trends
  • Competition Landscape by Key Players
  • Data by Type
  • Data by Application
  • North America Market Analysis
  • Europe Market Analysis
  • Asia-Pacific Market Analysis
  • Latin America Market Analysis
  • Middle East & Africa Market Analysis
  • Key Players Profiles Market Analysis
  • Analysts Viewpoints/Conclusions
  • Appendix

Get a trial of TOC https://www.predictivemarketresearch.com/toc/1023973#tableofcontents

Sections in the Medical & Hygiene PP Non Woven Fabric market research report:

Section 1: Mainly defines the market size, the rate at which the market is growing, and a macro overview of the Medical & Hygiene PP Non Woven Fabric. Gives a summary of different market segments by type, region, application, etc. This section gives a vivid description of the market of the Medical & Hygiene PP Non Woven Fabric.

Section 2: Gives a qualitative analysis of the current and future developments of the Medical & Hygiene PP Non Woven Fabric. It also tells about the growth of the Medical & Hygiene PP Non Woven Fabric and how the Medical & Hygiene PP Non Woven Fabric is helping in the growth and development of other countries.

Section 3: Gives an overview of the competitor analysis by providing data regarding the key market players and their performance in the Medical & Hygiene PP Non Woven Fabric. The section describes how the competitors' markets are performing, their strengths and weaknesses, and the prediction about how they might perform in the future.

Section 4: Focuses on the regional markets and gives detailed data of the regions and countries where the Medical & Hygiene PP Non Woven Fabric is performing well. It also predicts the future performance of the Medical & Hygiene PP Non Woven Fabric.

Section 5: Provides the analysis of the market segment based on deployment types, organization size, region, and industry vertical. It describes the recent trends and development of the Medical & Hygiene PP Non Woven Fabric market.

Section 6: This section deals with the requirement of the Medical & Hygiene PP Non Woven Fabric in the market and how the Medical & Hygiene PP Non Woven Fabric is assisting in the development of various industries. It also shows various opportunities the Medical & Hygiene PP Non Woven Fabric has in other industries.

Section 7: This section describes various frameworks like SWOT, PESTEL, Porter’s Five Forces, and other frameworks which deliver the industry analysis. This section helps the participants and key stakeholders to understand the industry well and take further action.

Section 8: This section covers the restrains and challenges the Medical & Hygiene PP Non Woven Fabric will face in various industries. The Medical & Hygiene PP Non Woven Fabric faces various issues related to security and data privacy.

Section9: This section summarizes the level of lucrativeness of venturing into a particular industry and gives a brief explanation for the same.

Highlights of The Medical & Hygiene PP Non Woven Fabric Market Report

The Medical & Hygiene PP Non Woven Fabric Market Industry Research Report contains:

  • The market research report of the Medical & Hygiene PP Non Woven Fabric defines, describes, and forecasts the Medical & Hygiene PP Non Woven Fabric market size and other market parameters.
  • The market research report of the Medical & Hygiene PP Non Woven Fabric gives an understanding of how the customers’ behavior pattern is tracked and how this tracking of data can lead to greater customer satisfaction.
  • The market research report shows how the Medical & Hygiene PP Non Woven Fabric can help in the growth and development of Small and Medium Industries (SMEs).
  • The report also emphasizes the need for AI and big data analytics for the bright future of the Medical & Hygiene PP Non Woven Fabric market.

COVID -19 Impact Analysis: https://www.predictivemarketresearch.com/enquiry/request-covid19/1023973

Medical & Hygiene PP Non Woven Fabric Market Research Reports report provides a comprehensive analysis of market size with the potential impact of COVID-19. The new global survey shows a positive impact of COVID-19 on the Medical & Hygiene PP Non Woven Fabric because of the increase in the use of internet services worldwide. The need for the Medical & Hygiene PP Non Woven Fabric became the maximum during the Covid-19 pandemic because of the changing consumer preference and behavior.

Medical & Hygiene PP Non Woven Fabric Market Size and Industry Challenges

Medical & Hygiene PP Non Woven Fabric market research report tells about the challenges and restraints faced by the Medical & Hygiene PP Non Woven Fabric. Although, the Medical & Hygiene PP Non Woven Fabric is witnessing positive growth figures yet there are certain obstacles that are yet to be solved.

Reasons to Purchase the Medical & Hygiene PP Non Woven Fabric Market Research Report

  • Information from the report gives the rate at which the Medical & Hygiene PP Non Woven Fabric market is growing thereby showing the potential it has in the future.
  • The research report of the Medical & Hygiene PP Non Woven Fabric market shows the opportunity the Medical & Hygiene PP Non Woven Fabric has in the market and helps the key stakeholders in making decisions for their businesses.
  • The report of the Medical & Hygiene PP Non Woven Fabric tells about the leading vendors operating in the market and the segment which provides the highest growth opportunity.
  • The report also contains information about the future trends of the Medical & Hygiene PP Non Woven Fabric market.

Purchase this report https://www.predictivemarketresearch.com/purchase/1023973 (Price 3900 USD for a Single-User License)

Contact Us:

Name: Aniket Tiwari

Email: sales@predictivemarketresearch.com

Phone: USA:+1 917 267 7384 / IN:+91 777 709 3097

Website: https://www.predictivemarketresearch.com/

Source:

Report Published by: Predictive Market Research

More Reports Published By Us:

Global and China High Melt Flow Polypropylene Market Insights, Forecast to 2027

Global and United States Ground Alumina Trihydrate Market Insights, Forecast to 2027

Global and United States Wet Alumina Trihydrate Market Insights, Forecast to 2027

Global and China Dry Alumina Trihydrate Market Insights, Forecast to 2027

Press Release Distributed by Lemon PR Wire

To view the original version on Lemon PR Wire visit Medical & Hygiene PP Non Woven Fabric Market Report, In-Depth Market Analysis and FORECAST 2022 To 2028 of market insights.

COMTEX_418128072/2788/2022-11-04T18:30:50

The MarketWatch News Department was not involved in the creation of this content.

Fri, 04 Nov 2022 06:30:00 -0500 en-US text/html https://www.marketwatch.com/press-release/medical-hygiene-pp-non-woven-fabric-market-report-in-depth-market-analysis-and-forecast-2022-to-2028-of-market-insights-2022-11-04
Killexams : Polk County medical facilities seeing surge in respiratory infections amid staffing challenges KCRG © Provided by Cedar Rapids KCRG-TV KCRG

DES MOINES, Iowa (KCRG) - Polk County health officials say clinics, hospitals, urgent cares and ER’s are seeing a high volume of patients due to respiratory infections like flu, RSV and COVID-19.

Healthcare officials also said the surge in patients comes amid staffing challenges, which includes staff illnesses.

Doctors are recommending people practice good hygiene and use healthcare resources appropriately.

For example, in a joint letter, doctors recommend calling your primary care provider first for any non-urgent health concerns. Urgent cares or walk-in clinics are also available for illnesses or injuries that are not life-threatening but may require fast attention.

The emergency rooms are for serious, life-threatening health issues, like heart attack symptoms, loss of consciousness, poisoning, or other potentially life-threatening conditions, and should not be used for anything other than emergencies as it could increase wait times for people in need of more urgent healthcare.

Other recommendations include wearing a mask and staying home when you are sick, and getting your flu and COVID-19 shots. They also recommend keeping up on routine checkups.

Fri, 02 Dec 2022 01:42:51 -0600 en-US text/html https://www.msn.com/en-us/health/medical/polk-county-medical-facilities-seeing-surge-in-respiratory-infections-amid-staffing-challenges/ar-AA14PeHw
Killexams : The effects of vaginal microbiome on women’s health

Over the last ten years, research into the vaginal microbiome and how it affects women’s overall health has significantly accelerated.

As scientists, academics, and medical experts build knowledge around the vaginal microbiome, increasing evidence indicates that an imbalance of the vaginal microflora can lead to disease, infections, and fertility problems in women.1

This article describes what the vaginal microbiome is, the properties of microorganisms that colonize the vagina, and how it impacts the overall health of women.

Covering the history of the vaginal microbiome, the aim of this article is to report how the exponential rise in research over the last decade is revolutionizing the development of diagnostic tests and treatments.

It becomes evident how different the vaginal microbiome is from other microbiomes of the human body in terms of bacteria, fungi, and viruses present and how this influences the body’s ability to combat infection and disease.

Technological innovations and advancements are being explored to help strengthen awareness and understanding of how new products and treatment solutions are being developed with the emergence of new human skin equivalent (HSE) models that simulate the vaginal microbiome. Moreover, there is an increased demand for microbiome-friendly intimate care products.

The effects if vaginal microbiome on women

Image Credit: Labskin

The future of vaginal microbiome research will also be explored to determine how advanced diagnostic tools and treatment solutions will be able to help researchers save time, Improve cost efficiency and widen its accessibility.

Approximately 95% of the Lactobacillus genera of bacteria make up normal vaginal flora, and the approximate pH balance of a healthy vagina is 4.5, the same as tomatoes and wine.

The effects if vaginal microbiome on women

Image Credit: Labskin

What is the vaginal microbiome?

The vaginal microbiome is a combined ecosystem of bacteria, yeasts, viruses, fungi, and other microorganisms that colonize the vagina.

The microbiome has a considerable role to play in a woman’s overall health; a balanced vaginal microbiome means the vagina is well-protected from pathogens and anaerobic bacteria, all of which help to prevent infections and other diseases.

With over one million bacterial genes, representing over 300 species of different bacteria in the vagina,3 Lactobacillus is the species that dominate the vaginal microbiome.

Lactobacilli create lactic acid to preserve a low, acidic pH within the vagina and impede the growth of undesirable pathogens such as Candida, E. coli, Gardnerella vaginalis, and Atopobium Vaginae.3 However, genes, ethnicity, and the physiological status of the vagina can also influence the balance of the vaginal microbiome.4

The effects if vaginal microbiome on women

Image Credit: Labskin

The history of vaginal microbiome research

In 1982, Albert Doderlein, a German obstetrician and gynecologist, first discovered a large gram-positive bacterium in the vagina, vaginal bacillus.5 Since then, additional studies have demonstrated that numerous kinds of vaginal communities exist in healthy women, comprised of different bacterial species depending on ethnicity and physiological states.

Typically, one of four common Lactobacillus will be dominant:

  • L. crispatus
  • L. iners
  • L. gasseri
  • L. jensenii

While lower proportions of lactic acid bacteria are seen in other vaginal community state types, a higher proportion of strictly anaerobic organisms is also likely.6

Recent progress in the technological field has facilitated an increase in the amount of data on the vaginal microbiome, such as the Human Vaginal Non-Redundant Gene Catalog, or VIRGO.

New diagnostic tests and treatments can now be evaluated as this tool includes the sequences of more than one million genes in bacteria, viruses, and fungi that are active in the vagina.7

There are approximately 300 species of bacteria in the vagina and roughly 1 million bacterial genes.

What does the vaginal microbiome do?

As with other microbiomes, such as the gut, skin, and scalp, the vaginal microbiome is specific to each individual.

However, its primary objective is to prevent infection and preserve good vaginal health. Race, ethnicity, hygiene, and behaviors all have a significant influence on the composition of a woman’s vaginal microflora. This means the microbiome continuously fluctuates throughout a woman’s life as a result of hormonal and lifestyle changes.

Numerous studies have been conducted to evaluate the effects of the vaginal microbiome on healthy reproduction, as it has been shown that any imbalance in the vaginal microflora may increase the risk of infertility, miscarriages, and preterm births.8

Interestingly, as microbes are passed onto the baby’s skin during delivery, a woman’s vaginal microflora can determine the skin microbiome of a newborn baby during birth. Whereas with cesarean birth, the mother’s stomach microflora is usually found.9

Vaginal dysbiosis, any disparity which affects the balance of the vaginal microbiome, may reduce the protective defenses of Lactobacilli; these may be the result of:

  • Antibiotics
  • Hormonal changes
  • Sexual activities
  • Douching
  • Bacterial vaginosis (BV)

Antibiotics have been historically designed to destroy bacterial infections in the body. Unfortunately, they also wipe out the good lactobacilli bacteria responsible for protecting the vagina from yeast and urinary tract infections.

Variations in hormonal activity as women age also impact the vaginal microbiome, as oestrogen typically preserves the number of lactobacilli within the vagina.10

Pregnant or pubescent females are susceptible to elevated amounts of oestrogen, which prevents imbalances. Whereas menopausal women usually experience a decline in oestrogen levels as they age, which may lead to vaginal dysbiosis. Once an imbalance in the vaginal microbiome occurs, women are at a higher risk of contracting urogenital disorders, such as:

  • Bacterial vaginosis (BV)
  • Sexually transmitted infections
  • Yeast infections
  • Urinary tract infections

The effects if vaginal microbiome on women

Image Credit: Labskin

Vaginal microbiome and vaginal diseases

The effects if vaginal microbiome on women

Image Credit: Labskin

No two women will have the same vaginal microbiome; this is due to factors such as race, age, and hormonal changes. This means there are a number of challenges when diagnosing and treating different types of vaginal disease.

However, with cutting-edge technologies, new ways of evaluating the vaginal microbiome and fluctuations that can be seen when infections take hold are giving space to a broader realm of research, helping to create products that can treat infections or prevent them from occurring in the first place.11

Treating vaginal disease or infections can be complicated, as symptoms vary between individuals. One of the key factors to take into consideration is a focus on the right diagnosis to treat the condition successfully, especially with ailments such as:

  • Bacterial vaginosis (BV)
  • Candida or yeast infections
  • Trichomoniasis
  • STDs, including chlamydia, genital herpes, and gonorrhea

Despite the number of oral and intravaginal treatments available, diagnosing and treating BV comes with a series of unique challenges. Failure to re-establish a healthy vaginal microbiome after infection and treatment means that infections recur in up to 50% of patients.12

The prevalence of BV is between 23% - 29% of the global female population while treating this condition costs around US $4.8 billion per year.13 Therefore, prevention and sustainable treatment strategies are absolutely necessary to decrease the burden of BV on women and prevent severe health outcomes.

Approximately $4.8 billion dollars is spent on treating bacterial vaginosis (BV) yearly.

The effects if vaginal microbiome on women

Image Credit: Labskin

Vaginal microbiome and technology advancements

The effects if vaginal microbiome on women

Image Credit: Labskin

Accelerating the discovery of new diagnostic testing and treatment solutions

Developing treatments for vaginal infections ran parallel to the accelerated pace at which the technology has progressed. Rather than focusing on molecular and culture-independent approaches to determine the bacteria associated with BV and other infections, researchers can now take advantage of different types of sequencing technology, including:

  • Next-generation genome sequencing
  • Single-cell genome sequencing
  • rRNA sequencing technology14

As established, genetic factors, physiological conditions, and environmental exposures all have an influence on the vaginal microbiome. However, sequencing technology, used in combination with human skin equivalent testing (HSE) innovations that mimic the vaginal microbiome, paves the way for faster, more reliable, and targeted intimate care products and treatments.15

To develop a deeper understanding of the vaginal ecosystem, species and strain level analyses used in combination with a plethora of other approaches are required to determine what intimate care products and treatments are not just safe to use but also prevent any disruption of the vaginal microbiome.

That is why cosmetic and medical companies are increasingly turning towards innovative HSE technology, as enhanced testing capabilities now make it possible to mimic the vaginal microbiome accurately in a laboratory setting.

Systems biology will also play a key role in understanding the vaginal microbiome in the future as more advanced Al and bioinformatic tools are developed,16 in conjunction with:

  • Metagenomics
  • Transcriptomics
  • Proteomics
  • Metabolomics

Knowledge relating to the individual strains of bacteria usually found in the vaginal microbiome, along with how and why it varies between women at different stages of life, is progressing continuously. It will continue to do so to ensure the demand for microbiome-friendly feminine hygiene and intimate care products is met.

The effects if vaginal microbiome on women

Image Credit: Labskin

Feminine hygiene and intimate care product markets

Demand for vaginal microbiome-friendly products is on the rise as consumers become increasingly aware of the importance of vaginal microbiome-friendly products when it comes to preventing disease and infections.

This means the markets for feminine hygiene and intimate care products are seeing a significant year-on-year increase across the globe. As of 2019, the feminine hygiene products market was $39.73 billion dollars, and it is expected to rise to $51.13 billion dollars by 2027 with a CAGR of 4.6%.17

Cosmetic and skincare companies are partnering with research and academic companies to meet this demand by testing and validating their products as consumers become increasingly self-aware of how certain products may cause imbalance and increase the risk of infections such as yeast and urinary tract infections.

With consumer knowledge continually growing as microbiome-friendly products for the skin, scalp, gut, and other microbiome regions of the body become more widely available18, so too will the demand for vaginal microbiome-friendly products, such as:

  • Menstrual hygiene products
  • Deodorizing wipes
  • Washes
  • Bathing products
  • Reusable and disposable intimate care products
  • Targeted probiotics for vaginal health 

As of 2019, the feminine hygiene products market was estimated to be worth $39.73 billion dollars. Yet, by 2027, it is expected to grow, reaching $51.13 billion dollars. 

Traditionally, the development of vaginal care products supported by clinical and efficacy testing standards took years due to the fluctuating amount of research material and the sheer amount of data to be interpreted in relation to the vaginal microbiome. 

However, it is now possible to address the challenges head-on with solutions that reduce research and development (R&D) costs and expedite the time it takes to bring new products to market that comply with regulatory, safety, and efficacy standards.19 

The effects if vaginal microbiome on women

Image Credit: Labskin

The future of the vaginal microbiome  

While research surrounding the vaginal microbiome is still in its early days, technological innovations and reductions in the cost of analysis have created a plethora of opportunities for cosmetic, skincare, and medical companies. 

Preventing or treating vaginal disease and infection is of utmost importance due to the extremity of problems that may arise when vaginal dysbiosis occurs. This is followed by the increased demand for feminine care products that can ease symptoms associated with thrush and urinary tract infections and also prevent toxic shock syndrome (TSS). 

More research is underway regarding the pathogenesis of bacterial vaginosis, ways to optimize BV treatments, and the role that sexual transmissions and endogenous infections play in BV epidemiology.20  

When studied in conjunction with the vaginal microbiome, cosmetic, skincare, and medical companies will have a summary of the effects of intimate care products on the vaginal microbiome and will thus be able to offer products specific to females depending on their age, ethnicity, hormonal, and lifestyle factors. 

Early diagnoses and enhanced treatment solutions can be accomplished by swabbing the vaginal microbiome to assess disease markers that could reveal women’s susceptibility to certain infections, especially when used in conjunction with improved AI diagnostic and big data tools. 

Now that there has been an increased reduction regarding animal testing on cosmetics and skin care products,21 the technological breakthrough of human skin equivalent (HSE) models will lead the way in vaginal microbiome research. 

Clinical trial participant numbers can be halved by cloning data to mimic multiple test subjects, saving time and costs to bring safe and validated products to market. 

Labskin’s 3D model for testing the vaginal microbiome 

Over the last decade, Labskin researchers and scientists have worked relentlessly to develop a commercial lab-grown, full-thickness human skin equivalent that simulates the vaginal microbiome and supports the research surrounding the impact of cosmetics, pharmaceuticals, and skincare products on the body’s microbiota. 

While other living skin equivalents have been around for a while, Labskin’s 3D model is the first with the capacity to colonize skin microflora, ensuring the most accurate results from tests without conducting expensive and time-consuming human trials or the need for animal testing. 

Labskin has made access to this technology available to commercial and research institutions and encourages project collaboration to enhance the knowledge surrounding the workings of the vaginal microbiome s. 

Labskin AI technology facilitates the creation of a repository of data and predictive analysis, supporting industry and academia in developing ethical discoveries and strategies for new hygiene and care products as well as advancements in medicine. 

References 

  1. White, B.A., Creedon, D.J., Nelson, K.E., & Wilson, B.A. (2011, July 13). ‘The vaginal microbiome in health and disease
  2. Brouillette, M. (2020, February 28). "Decoding the vaginal microbiome" 
  3. The Gynoe Center. (2021, February 18). “What your vaginal microbiome con tell you about your feminine health” 
  4. Buchta, V. (2018). "Vaginal microbiome" 
  5. Wikipedia. (2020, June 5). "Albert Doderlein"
  6. Ravel, J., Gojer, P., Abdo, Z., Schneider, G.N., Keonig, S.S.K., McCulle, S.L., Korleboch, S., Gorle, R., Russell, J.,  
  7. Tacket, C.O., Brotman, R.M., Davis, C.C., Ault, K., Perolta, L., & Forney, L.J. (2010, June 3). “Vaginal microbiome of reproductive-age women”  
  8. Mo, B., Fronce, M.T., Crabtree, J., Holm, J.B., Humphrys, M.S., Brotman, R.M., & Ravel, J. (2020, February 26). “A comprehensive non-redundant gene catalog reveals extensive within-community introspecies diversity in the human vagina”  
  9. Xu, J., Bion, G., Zheng, M., Lu, G., Chon, WY., Li, W., Yong, K., Chen, Z.J., & Du, Y. (2020, January 21). “Fertility factors affect the vaginal microbiome in women of reproductive age” 
  10. Labskin. (2020). “An introduction to the skin microbiome” Whitepoper  
  11. The Gynoe Center. (2021, Februory 18). “What your vaginal microbiome con tell you about your feminine health” 
  12. Labskin. (2021, Morch) “Viruses on Lobskin” Lobskin Morch Seminar 
  13. Muzny, C.A., & Kordas, P. (2020, Morch 27). “A narrative review of current challenges in the diagnosis and management of bacterial voginosis”
  14. Peebles, K., Vellozo, J., Balkus, J.E., McClelland, R.S., & Barnabas, RV (2019, Moy). “High global burden and costs of bacterial voginosis: A systemic review and meta-analysis”
  15. Fettweis, J.M., Serrano, M.G., Girerd, P.H., Jefferson, K.K., & Buck, G.A. (2012, Moy 1). “A new era of the vaginal microbiome: Advances using next-generation sequencing” 
  16. Labskin. (2019, October 10). “Exploring the safety of hygienic tampons” 
  17. Mortin, D.H., & Marrazzo, J.M. (2016, July 19). “The vaginal microbiome: Current understanding and future directions”

About Labskin

At Labskin we deliver human skin microbiology services to support your product R&D activities in the cosmetic, personal care, medical device and pharmaceutical sectors. With our sector experience and use of technology, you will be accessing industry-focused services supported by world-leading skin science expertise.

Whether you need rapid, focused analysis or flexible, tailor-made research programs we can help you develop and validate skincare ingredients and products which really work.

Our skin model is a 3D human skin equivalent that incorporates vital biological components to model normal skin function. Developed over 12 years with more than 30 scientific journal publications, it is made from young keratinocytes (human skin cells) and adult fibroblasts (metabolically-active, collagen-producing human skin cells).

“An ideal platform for basic or applied skin research, testing compounds or formulated products for the cosmetic, pharmaceutical and chemical sectors.”


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Wed, 07 Dec 2022 23:36:00 -0600 en text/html https://www.news-medical.net/whitepaper/20221208/The-effects-of-vaginal-microbiome-on-womene28099s-health.aspx
Killexams : Medical clinic in Dallas will offer free care to hundreds: What you need to know Clara Solorzano, a second year dental hygiene student at Tarrant Community College, cleans ten-year-old Dayana Salazar’s teeth in November 2021. Both children and adults will be able to get free medical, dental and vision care in December through a two-day clinic from Remote Area Medical. Dental services are the most requested services at RAM clinics, and are available on a first-come, first-served basis. © Amanda McCoy/Star-Telegram/TNS Clara Solorzano, a second year dental hygiene student at Tarrant Community College, cleans ten-year-old Dayana Salazar’s teeth in November 2021. Both children and adults will be able to get free medical, dental and vision care in December through a two-day clinic from Remote Area Medical. Dental services are the most requested services at RAM clinics, and are available on a first-come, first-served basis.

Hundreds of North Texans will be able to get free medical, vision, and dental care in December thanks to the return of the Remote Area Medical traveling clinic.

Established in 1985, Remote Area Medical is a nonprofit that travels throughout the U.S. and the world providing free care to people in need. In the U.S., the clinic has become best known for attracting hundreds or thousands of people at each clinic location, where people without health insurance or who can’t afford their health insurance co-payments flock to receive basic care.

The RAM clinic will be in Dallas Dec. 3-4 at the Kay Bailey Hutchison Convention Center, 650 S. Griffin St. This is the second year in a row for the RAM clinic to serve the Dallas-Fort Worth area. Last year, more than 400 people received care when the clinic was in north Fort Worth. Organizers expect the Dallas location to be able to serve more people this year because the convention center is accessible via public transportation.

RAM is partnering with the University of North Texas Health Science Center for its Dallas clinic. HSC students will join other volunteers to staff the clinic.

Adults and children of all ages can attend the clinic. No identification, proof of insurance or proof of residency paperwork is required to receive care, said Audra Fitzgerald, senior clinic coordinator for RAM. On both Dec. 3 and 4, the clinic will open at 6 a.m. and will continue treating patients until all providers are at capacity.

Fitzgerald said she recommended lining up before the clinic opens if you are in need of dental care. All care is available on a first-come, first-served basis.

“Dental is probably our most requested service,” Fitzgerald said.

The patient parking lot will open by 11:59 p.m. on Dec. 2. If you decide to line up overnight, Fitzgerald recommended bringing enough food, water, and medication to last you the night, as well as additional seating and coats or blankets to keep you warm. Portable bathrooms will be available.

All patients can receive medical care, but patients must choose between either dental or vision care. The dental care available includes dental cleanings, fillings, extractions and x-rays. Vision care includes eye exams, glaucoma testing and prescription eyeglasses that are made on site.

©2022 Fort Worth Star-Telegram. Visit star-telegram.com. Distributed by Tribune Content Agency, LLC.

Thu, 24 Nov 2022 22:00:00 -0600 en-US text/html https://www.msn.com/en-us/health/other/medical-clinic-in-dallas-will-offer-free-care-to-hundreds-what-you-need-to-know/ar-AA14xz67
Killexams : Blood Stream Infection Testing Market [ NEW REPORT ] Industry Expansion Tactics by Top Players in Medical Care Sector till 2028

The MarketWatch News Department was not involved in the creation of this content.

Dec 05, 2022 (The Expresswire) -- ""Blood Stream Infection Testing Market"" Research report Insights 2023 | Number of Tables and Figures [ 135 ] Blood Stream Infection Testing Market cover market size for segment By Types [Conventional Blood Culture Tests, PCR Methods, Nucleic Acid Testing, Mass Spectroscopy, Point of Care Testing ], by Applications [Hospitals, Independent Diagnostic Centers, Others] offers extensive forecasts from 2023-2028. According to Our Research the [ Medical Care ] Industry is dominated and accounted for the major income share In 2022. The major market players are taking massive steps to increase their market position through developing countries, including increasing research and development investments and constant mergers and acquisitions.

Who is the key manufacturer in the Global?

Some of the prominent players in the global Blood Stream Infection Testing market include:

● BD
● bioMérieux
● Cepheid
● Roche Diagnostics
● IRIDICA
● Bruker
● Nanosphere
● Siemens
● AdvanDX

And More…

Get a trial Copy of the Blood Stream Infection Testing Market Report 2023

What are Industry Insights?

BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Blood Stream Infection Testing estimated at USD 3949.8 million in the year 2023, is projected to reach a revised size of USD 5862.7 million by 2028, growing at a CAGR of 6.8% during the forecast period 2023-2028.

Bloodstream infections are mostly diagnosed by blood culture tests and molecular tests. Commercially available tests are SepsiTest, SeptiFast, MagicPlex, VYOO, and PLEX-ID. The global bloodstream infection testing market is driven by the growing incidence and prevalence of burn/wounds cases, HIV, pneumonia, pyelonephritis, and cancer. Additionally, awareness about hygiene, diagnosis rate, unhealthy lifestyle, and increase in geriatric population are the potential factors for the market growth. On the other hand, rigid regulatory scenario regarding diagnosis procedures, high diagnosis cost, and lack of medical reimbursement may hinder the growth of the market during the forecast period. Innovations, RandD investments, mergers and acquisitions among the key vendors are the dynamics for the bloodstream infection testing market to progress.ÂÂ

The report includes six parts, dealing with:

1.) Basic Information

2.) Asia Blood Stream Infection Testing Market

3.) North American Blood Stream Infection Testing Market

4.) European Blood Stream Infection Testing Market

5.) Market Entry and Investment Feasibility

6.) Report Conclusion

Get a trial PDF of report -https://www.marketgrowthreports.com/enquiry/request-sample/21958600

The Global Blood Stream Infection Testing market is likely to growth at a substantial rate during the forecast period, between 2023 and 2028. In 2023, the market is growing at a steady rate and with the increasing adoption of tactics by key players, the market is predicted to rise over the projected horizon.

The report is divided into three parts:

Part I- Market Overview

Part II- Market Data

Part III- Strategic Recommendations

Blood Stream Infection Testing Market - Competitive and Segmentation Analysis:

This Blood Stream Infection Testing Market report offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2023. The report also includes company description, major business, Blood Stream Infection Testing product introduction, recent developments and Blood Stream Infection Testing sales by region, type, application and by sales channel.

Report further studies the market development status and future Blood Stream Infection Testing Market trend across the world. Also, it splits Blood Stream Infection Testing market Segmentation by Type and by Applications to fully and deeply research and reveal market profile and prospects.

Final Report will add the analysis of the impact of COVID-19 on this industry.

TO KNOW HOW COVID-19 PANDEMIC AND RUSSIA UKRAINE WAR WILL IMPACT THIS MARKET - REQUEST SAMPLE

Blood Stream Infection Testing Market - Covid-19 Impact and Recovery Analysis:

We have been following the straight effect of COVID-19 on this market, as well as the circuitous effect from different industries. This report investigates the effect of the pandemic on the Blood Stream Infection Testing market from a Global and Regional point of view. The report frames the market size, market appearances, and market development for Blood Stream Infection Testing industry, ordered by type, application, and consumer area. Likewise, it gives an extensive examination of perspectives engaged with market improvement when the Covid-19 pandemic. Report likewise directed a PESTEL analysis in the business to concentrate on key influencers and boundaries to entry.

It also provides accurate information and cutting-edge analysis that is necessary to formulate an ideal business plan, and to define the right path for rapid growth for all involved industry players. With this information, stakeholders will be more capable of developing new strategies, which focus on market opportunities that will benefit them, making their business endeavors profitable in the process.

On the basis of product typethis report displays the production, revenue, price, market share and growth rate of each type, primarily split into:

● Conventional Blood Culture Tests
● PCR Methods
● Nucleic Acid Testing
● Mass Spectroscopy
● Point of Care Testing

On the basis of the end users/applicationsthis report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including:

● Hospitals
● Independent Diagnostic Centers
● Others

Blood Stream Infection Testing Market - Regional Analysis:

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Blood Stream Infection Testing in these regions, from 2015 to 2028, covering

● North America (United States, Canada and Mexico) ● Europe (Germany, UK, France, Italy, Russia and Turkey etc.) ● Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam) ● South America (Brazil, Argentina, Columbia etc.) ● Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Some of the key questions answered in this report:

● What is the global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) sales value, production value, consumption value, import and export of Blood Stream Infection Testing? ● Who are the global key manufacturers of the Blood Stream Infection Testing Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)? ● What are the Blood Stream Infection Testing market opportunities and threats faced by the vendors in the global Blood Stream Infection Testing Industry? ● Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application? ● What focused approach and constraints are holding the Blood Stream Infection Testing market? ● What are the different sales, marketing, and distribution channels in the global industry? ● What are the upstream raw materials and manufacturing equipment of Blood Stream Infection Testing along with the manufacturing process of Blood Stream Infection Testing? ● What are the key market trends impacting the growth of the Blood Stream Infection Testing market? ● Economic impact on the Blood Stream Infection Testing industry and development trend of the Blood Stream Infection Testing industry. ● What are the market opportunities, market risk, and market overview of the Blood Stream Infection Testing market? ● What are the key drivers, restraints, opportunities, and challenges of the Blood Stream Infection Testing market, and how they are expected to impact the market? ● What is the Blood Stream Infection Testing market size at the regional and country-level?

Our research analysts will help you to get customized details for your report, which can be modified in terms of a specific region, application or any statistical details. In addition, we are always willing to comply with the study, which triangulated with your own data to make the market research more comprehensive in your perspective.

Inquire more and share questions if any before the purchase on this report at -https://www.marketgrowthreports.com/enquiry/pre-order-enquiry/21958600

Detailed TOC of Global Blood Stream Infection Testing Market Research Report 2023

1 Blood Stream Infection Testing Market Overview

1.1 Product Overview and Scope of Blood Stream Infection Testing
1.2 Blood Stream Infection Testing Segment by Type
1.2.1 Global Blood Stream Infection Testing Market Size Growth Rate Analysis by Type 2023 VS 2028
1.3 Blood Stream Infection Testing Segment by Application
1.3.1 Global Blood Stream Infection Testing Consumption Comparison by Application: 2023 VS 2028
1.4 Global Market Growth Prospects
1.4.1 Global Blood Stream Infection Testing Revenue Estimates and Forecasts (2015-2028)
1.4.2 Global Blood Stream Infection Testing Production Capacity Estimates and Forecasts (2015-2028)
1.4.3 Global Blood Stream Infection Testing Production Estimates and Forecasts (2015-2028)
1.5 Global Market Size by Region
1.5.1 Global Blood Stream Infection Testing Market Size Estimates and Forecasts by Region: 2015 VS 2023 VS 2028
1.5.2 North America Blood Stream Infection Testing Estimates and Forecasts (2015-2028)
1.5.3 Europe Blood Stream Infection Testing Estimates and Forecasts (2015-2028)
1.5.4 China Blood Stream Infection Testing Estimates and Forecasts (2015-2028)
1.5.5 Japan Blood Stream Infection Testing Estimates and Forecasts (2015-2028)

2 Market Competition by Manufacturers
2.1 Global Blood Stream Infection Testing Production Capacity Market Share by Manufacturers (2015-2023)
2.2 Global Blood Stream Infection Testing Revenue Market Share by Manufacturers (2015-2023)
2.3 Blood Stream Infection Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Blood Stream Infection Testing Average Price by Manufacturers (2015-2023)
2.5 Manufacturers Blood Stream Infection Testing Production Sites, Area Served, Product Types
2.6 Blood Stream Infection Testing Market Competitive Situation and Trends
2.6.1 Blood Stream Infection Testing Market Concentration Rate
2.6.2 Global 5 and 10 Largest Blood Stream Infection Testing Players Market Share by Revenue
2.6.3 Mergers and Acquisitions, Expansion

3 Production Capacity by Region
3.1 Global Production Capacity of Blood Stream Infection Testing Market Share by Region (2015-2023)
3.2 Global Blood Stream Infection Testing Revenue Market Share by Region (2015-2023)
3.3 Global Blood Stream Infection Testing Production Capacity, Revenue, Price and Gross Margin (2015-2023)
3.4 North America Blood Stream Infection Testing Production
3.4.1 North America Blood Stream Infection Testing Production Growth Rate (2015-2023)
3.4.2 North America Blood Stream Infection Testing Production Capacity, Revenue, Price and Gross Margin (2015-2023)
3.5 Europe Blood Stream Infection Testing Production
3.5.1 Europe Blood Stream Infection Testing Production Growth Rate (2015-2023)
3.5.2 Europe Blood Stream Infection Testing Production Capacity, Revenue, Price and Gross Margin (2015-2023)
3.6 China Blood Stream Infection Testing Production
3.6.1 China Blood Stream Infection Testing Production Growth Rate (2015-2023)
3.6.2 China Blood Stream Infection Testing Production Capacity, Revenue, Price and Gross Margin (2015-2023)
3.7 Japan Blood Stream Infection Testing Production
3.7.1 Japan Blood Stream Infection Testing Production Growth Rate (2015-2023)
3.7.2 Japan Blood Stream Infection Testing Production Capacity, Revenue, Price and Gross Margin (2015-2023)

4 Global Blood Stream Infection Testing Consumption by Region
4.1 Global Blood Stream Infection Testing Consumption by Region
4.1.1 Global Blood Stream Infection Testing Consumption by Region
4.1.2 Global Blood Stream Infection Testing Consumption Market Share by Region
4.2 North America
4.2.1 North America Blood Stream Infection Testing Consumption by Country
4.2.2 United States
4.2.3 Canada
4.3 Europe
4.3.1 Europe Blood Stream Infection Testing Consumption by Country
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Blood Stream Infection Testing Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 China Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Blood Stream Infection Testing Consumption by Country
4.5.2 Mexico
4.5.3 Brazil

Get a trial Copy of the Blood Stream Infection Testing Market Report 2023

5 Segment by Type
5.1 Global Blood Stream Infection Testing Production Market Share by Type (2015-2023)
5.2 Global Blood Stream Infection Testing Revenue Market Share by Type (2015-2023)
5.3 Global Blood Stream Infection Testing Price by Type (2015-2023)
6 Segment by Application
6.1 Global Blood Stream Infection Testing Production Market Share by Application (2015-2023)
6.2 Global Blood Stream Infection Testing Revenue Market Share by Application (2015-2023)
6.3 Global Blood Stream Infection Testing Price by Application (2015-2023)

7 Key Companies Profiled
7.1 Company
7.1.1 Blood Stream Infection Testing Corporation Information
7.1.2 Blood Stream Infection Testing Product Portfolio
7.1. CBlood Stream Infection Testing Production Capacity, Revenue, Price and Gross Margin (2015-2023)
7.1.4 Company’s Main Business and Markets Served
7.1.5 Company’s recent Developments/Updates

8 Blood Stream Infection Testing Manufacturing Cost Analysis
8.1 Blood Stream Infection Testing Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Blood Stream Infection Testing
8.4 Blood Stream Infection Testing Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Blood Stream Infection Testing Distributors List
9.3 Blood Stream Infection Testing Customers

10 Market Dynamics
10.1 Blood Stream Infection Testing Industry Trends
10.2 Blood Stream Infection Testing Market Drivers
10.3 Blood Stream Infection Testing Market Challenges
10.4 Blood Stream Infection Testing Market Restraints

11 Production and Supply Forecast
11.1 Global Forecasted Production of Blood Stream Infection Testing by Region (2023-2028)
11.2 North America Blood Stream Infection Testing Production, Revenue Forecast (2023-2028)
11.3 Europe Blood Stream Infection Testing Production, Revenue Forecast (2023-2028)
11.4 China Blood Stream Infection Testing Production, Revenue Forecast (2023-2028)
11.5 Japan Blood Stream Infection Testing Production, Revenue Forecast (2023-2028)

12 Consumption and Demand Forecast
12.1 Global Forecasted Demand Analysis of Blood Stream Infection Testing
12.2 North America Forecasted Consumption of Blood Stream Infection Testing by Country
12.3 Europe Market Forecasted Consumption of Blood Stream Infection Testing by Country
12.4 Asia Pacific Market Forecasted Consumption of Blood Stream Infection Testing by Region
12.5 Latin America Forecasted Consumption of Blood Stream Infection Testing by Country

13 Forecast by Type and by Application (2023-2028)
13.1 Global Production, Revenue and Price Forecast by Type (2023-2028)
13.1.1 Global Forecasted Production of Blood Stream Infection Testing by Type (2023-2028)
13.1.2 Global Forecasted Revenue of Blood Stream Infection Testing by Type (2023-2028)
13.1.3 Global Forecasted Price of Blood Stream Infection Testing by Type (2023-2028)
13.2 Global Forecasted Consumption of Blood Stream Infection Testing by Application (2023-2028)
13.2.1 Global Forecasted Production of Blood Stream Infection Testing by Application (2023-2028)
13.2.2 Global Forecasted Revenue of Blood Stream Infection Testing by Application (2023-2028)
13.2.3 Global Forecasted Price of Blood Stream Infection Testing by Application (2023-2028)

14 Research Finding and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

Continued….

Purchase this report (Price 5600 USD for a single-user license) -https://www.marketgrowthreports.com/purchase/21958600

About Us:

Market is changing rapidly with the ongoing expansion of the industry. Advancement in the technology has provided today’s businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies with a head start in planning and an edge over the competitors. Market Growth Reports is the credible source for gaining the market reports that will provide you with the lead your business needs.

Contact Us:

Market growth reports

Phone : US +1 424 253 0946

UK +44 203 239 8187

Email :sales@marketgrowthreports.com

Web : https://www.marketgrowthreports.com

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Blood Stream Infection Testing Market [ NEW REPORT ] Industry Expansion Tactics by Top Players in Medical Care Sector till 2028

COMTEX_420249798/2598/2022-12-05T09:31:12

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Mon, 05 Dec 2022 01:28:00 -0600 en-US text/html https://www.marketwatch.com/press-release/blood-stream-infection-testing-market-new-report-industry-expansion-tactics-by-top-players-in-medical-care-sector-till-2028-2022-12-05
Killexams : London School of Hygiene & Tropical Medicine Selects Zenoss to Ensure Availability of IT Services

AUSTIN, Texas--()--Zenoss Inc., the leader in AI-driven full-stack monitoring, today announced renowned research institution London School of Hygiene & Tropical Medicine (LSHTM) has selected Zenoss to provide a unified view of their IT services and operations, which are mission critical to their academics, research and students worldwide.

LSHTM is a leader in research, postgraduate studies and continuing education in public and global health. The school has an annual research income of more than $200 million and is one of the highest-rated research institutions in the United Kingdom. They have 3,500 staff members conducting research in over 100 countries, and more than 4,750 students all working with a collective purpose to Improve health across the world.

Zenoss Cloud enables LSHTM’s global IT operations and services team to have visibility and awareness across their growing and increasingly complex hybrid IT infrastructure. This includes two major data centers in London running virtualized workloads, traditional physical resources such as HPC, servers and SANs, as well as a growing number of core services hosted in the cloud and across localized IT operations centers in Africa and other parts of the world.

“Our IT services run across a multitude of environments and need to be up and running at all times to support our students and faculty,” said Steven Whitebread, the core systems and infrastructure manager at LSHTM. “As our services and operations have grown, our systems have become more interconnected, and the dependencies in those systems have also grown. Being able to easily and proactively monitor service availability and trend metrics with Zenoss enables us to plan and adapt our systems to provide a better quality of service and to predict IT service issues before they lead to service disruptions.”

Zenoss is the leading AI-driven full-stack monitoring platform that streams all machine data, uniquely enabling the emergence of context for preventing service disruptions in complex, modern IT environments. Zenoss leverages the most powerful machine learning and real-time analytics to deliver companies the ability to scale and adapt to the changing needs of their businesses.

"Zenoss is focused on enabling our customers to optimize services and operations and ensuring the performance of their IT environments," said Greg Stock, CEO of Zenoss. "We're extremely proud to be trusted by LSHTM as they continue to advance research and help shape health policy around the world."

To learn more about Zenoss, visit https://www.zenoss.com/product.

About Zenoss

Zenoss works with the world's largest organizations to ensure their IT services and applications are always on. Delivering full-stack monitoring combined with AIOps, Zenoss uniquely collects all types of machine data, including metrics, dependency data, events, streaming data and logs, to build real-time IT service models that train machine learning algorithms to deliver robust AIOps analytics capabilities. This enables IT Ops and DevOps teams to optimize application performance, predict and eliminate outages, and reduce IT spend in modern hybrid IT environments. Zenoss is recognized in the 2022 Gartner Market Guide for AIOps Platforms and in the 2022 Gartner Market Guide for IT Infrastructure Monitoring Tools. For more information about Zenoss, please visit https://www.zenoss.com.

Thu, 10 Nov 2022 01:46:00 -0600 en text/html https://www.businesswire.com/news/home/20221110005814/en/London-School-of-Hygiene-Tropical-Medicine-Selects-Zenoss-to-Ensure-Availability-of-IT-Services
Killexams : ‘Personal Hygiene’ Spat Led 21-Year-Old Texas Inmate to Murder 62-Year-Old Cellmate by ‘Punching Him and Stomping on His Head’: Reports

Luke Christopher Pena. (Image via jail mugshot.)

A Texas jail inmate is now facing murder charges for allegedly attacking his cellmate as the victim slept.  The victim languished in the hospital for nearly three weeks until succumbing to his injuries on Wednesday, according to San Antonio CBS affiliate KENS.

A Bexar County court docket reviewed by Law&Crime says Luke Christopher Pena, 21, was charged with murder via a Nov. 23, 2022 criminal complaint. A grand jury indictment has not yet occurred, the records indicate.

A report from San Antonio ABC affiliate KSAT says Pena attacked Gilbert Zepeda, 62, as Zepeda slept.  Zepeda died later at Brooke Army Medical Center after a craniotomy attempted unsuccessfully to alleviate a brain injury, the television station said.

Zepeda died at 4:35 p.m. Wednesday from “cardiopulmonary arrest due to an assault,” according to an affidavit obtained by KSAT.

The Texas Rangers were called at 7:15 p.m. (presumably on the date the attack occurred, but the dates in the available television reports are slightly unclear) as an outside agency to investigate the matter.

KENS listed the attack date as Thursday, Nov. 3.  It also listed Zepeda’s age as 61 rather than the aforementioned 62.

A jail sergeant told a Texas Ranger that “Pena had assaulted his cellmate,” according to KSAT’s retelling of the affidavit.

Citing that same document, both previously referenced television stations — and NBC affiliate WOAI — all said Pena claimed Zepeda had “disrespected him” in some fashion.  The details and parameters of that alleged disrespect are not explained in the available reports.

The reports also collectively say Pena found Zepeda’s personal hygiene objectionable and that he intended to kill Zepeda.

“Pena admitted that he waited for Zepeda to fall asleep before punching him and stomping on his head,” KSAT reported. “He said it was an attempt to kill Zepeda.”

The authorities, by alleging murder, have accused Pena of “intentionally and knowingly caused Zepeda’s death,” KSAT continued.

Pena reportedly remains in the Bexar County Jail pending a Jan. 18, 2023 court hearing.

Other court records reviewed by Law&Crime suggest Pena was jailed on a series of previous charges dated Oct. 30, 2022, including criminal mischief, kidnapping, theft, failure to stop, and aggravated assault resulting in severe bodily injury.

The reason Zepeda was in jail is unclear from online inmate and court records.

The post ‘Personal Hygiene’ Spat Led 21-Year-Old Texas Inmate to Murder 62-Year-Old Cellmate by ‘Punching Him and Stomping on His Head’: Reports first appeared on Law & Crime.

Sat, 26 Nov 2022 09:51:58 -0600 en-US text/html https://www.msn.com/en-us/news/crime/e2-80-98personal-hygiene-e2-80-99-spat-led-21-year-old-texas-inmate-to-murder-62-year-old-cellmate-by-e2-80-98punching-him-and-stomping-on-his-head-e2-80-99-reports/ar-AA14AAup
Killexams : London School of Hygiene & Tropical Medicine Selects Zenoss to Ensure Availability of IT Services

AI-Driven Full-Stack Monitoring Gives Research Institution End-to-End Visibility

AUSTIN, Texas, November 10, 2022--(BUSINESS WIRE)--Zenoss Inc., the leader in AI-driven full-stack monitoring, today announced renowned research institution London School of Hygiene & Tropical Medicine (LSHTM) has selected Zenoss to provide a unified view of their IT services and operations, which are mission critical to their academics, research and students worldwide.

LSHTM is a leader in research, postgraduate studies and continuing education in public and global health. The school has an annual research income of more than $200 million and is one of the highest-rated research institutions in the United Kingdom. They have 3,500 staff members conducting research in over 100 countries, and more than 4,750 students all working with a collective purpose to Improve health across the world.

Zenoss Cloud enables LSHTM’s global IT operations and services team to have visibility and awareness across their growing and increasingly complex hybrid IT infrastructure. This includes two major data centers in London running virtualized workloads, traditional physical resources such as HPC, servers and SANs, as well as a growing number of core services hosted in the cloud and across localized IT operations centers in Africa and other parts of the world.

"Our IT services run across a multitude of environments and need to be up and running at all times to support our students and faculty," said Steven Whitebread, the core systems and infrastructure manager at LSHTM. "As our services and operations have grown, our systems have become more interconnected, and the dependencies in those systems have also grown. Being able to easily and proactively monitor service availability and trend metrics with Zenoss enables us to plan and adapt our systems to provide a better quality of service and to predict IT service issues before they lead to service disruptions."

Zenoss is the leading AI-driven full-stack monitoring platform that streams all machine data, uniquely enabling the emergence of context for preventing service disruptions in complex, modern IT environments. Zenoss leverages the most powerful machine learning and real-time analytics to deliver companies the ability to scale and adapt to the changing needs of their businesses.

"Zenoss is focused on enabling our customers to optimize services and operations and ensuring the performance of their IT environments," said Greg Stock, CEO of Zenoss. "We're extremely proud to be trusted by LSHTM as they continue to advance research and help shape health policy around the world."

To learn more about Zenoss, visit https://www.zenoss.com/product.

About Zenoss

Zenoss works with the world's largest organizations to ensure their IT services and applications are always on. Delivering full-stack monitoring combined with AIOps, Zenoss uniquely collects all types of machine data, including metrics, dependency data, events, streaming data and logs, to build real-time IT service models that train machine learning algorithms to deliver robust AIOps analytics capabilities. This enables IT Ops and DevOps teams to optimize application performance, predict and eliminate outages, and reduce IT spend in modern hybrid IT environments. Zenoss is recognized in the 2022 Gartner Market Guide for AIOps Platforms and in the 2022 Gartner Market Guide for IT Infrastructure Monitoring Tools. For more information about Zenoss, please visit https://www.zenoss.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005814/en/

Contacts

Jill Ford
pr@zenoss.com

Thu, 10 Nov 2022 01:49:00 -0600 en-US text/html https://www.yahoo.com/now/london-school-hygiene-tropical-medicine-153100850.html
Killexams : London School of Hygiene & Tropical Medicine Selects Zenoss to Ensure Availability of IT Services

AI-Driven Full-Stack Monitoring Gives Research Institution End-to-End Visibility

AUSTIN, Texas, November 10, 2022--(BUSINESS WIRE)--Zenoss Inc., the leader in AI-driven full-stack monitoring, today announced renowned research institution London School of Hygiene & Tropical Medicine (LSHTM) has selected Zenoss to provide a unified view of their IT services and operations, which are mission critical to their academics, research and students worldwide.

LSHTM is a leader in research, postgraduate studies and continuing education in public and global health. The school has an annual research income of more than $200 million and is one of the highest-rated research institutions in the United Kingdom. They have 3,500 staff members conducting research in over 100 countries, and more than 4,750 students all working with a collective purpose to Improve health across the world.

Zenoss Cloud enables LSHTM’s global IT operations and services team to have visibility and awareness across their growing and increasingly complex hybrid IT infrastructure. This includes two major data centers in London running virtualized workloads, traditional physical resources such as HPC, servers and SANs, as well as a growing number of core services hosted in the cloud and across localized IT operations centers in Africa and other parts of the world.

"Our IT services run across a multitude of environments and need to be up and running at all times to support our students and faculty," said Steven Whitebread, the core systems and infrastructure manager at LSHTM. "As our services and operations have grown, our systems have become more interconnected, and the dependencies in those systems have also grown. Being able to easily and proactively monitor service availability and trend metrics with Zenoss enables us to plan and adapt our systems to provide a better quality of service and to predict IT service issues before they lead to service disruptions."

Zenoss is the leading AI-driven full-stack monitoring platform that streams all machine data, uniquely enabling the emergence of context for preventing service disruptions in complex, modern IT environments. Zenoss leverages the most powerful machine learning and real-time analytics to deliver companies the ability to scale and adapt to the changing needs of their businesses.

"Zenoss is focused on enabling our customers to optimize services and operations and ensuring the performance of their IT environments," said Greg Stock, CEO of Zenoss. "We're extremely proud to be trusted by LSHTM as they continue to advance research and help shape health policy around the world."

To learn more about Zenoss, visit https://www.zenoss.com/product.

About Zenoss

Zenoss works with the world's largest organizations to ensure their IT services and applications are always on. Delivering full-stack monitoring combined with AIOps, Zenoss uniquely collects all types of machine data, including metrics, dependency data, events, streaming data and logs, to build real-time IT service models that train machine learning algorithms to deliver robust AIOps analytics capabilities. This enables IT Ops and DevOps teams to optimize application performance, predict and eliminate outages, and reduce IT spend in modern hybrid IT environments. Zenoss is recognized in the 2022 Gartner Market Guide for AIOps Platforms and in the 2022 Gartner Market Guide for IT Infrastructure Monitoring Tools. For more information about Zenoss, please visit https://www.zenoss.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005814/en/

Contacts

Jill Ford
pr@zenoss.com

Thu, 10 Nov 2022 01:34:00 -0600 en-NZ text/html https://nz.finance.yahoo.com/news/london-school-hygiene-tropical-medicine-153100850.html
CDCA-ADEX exam dump and training guide direct download
Training Exams List